J. Kao

发表

Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms.

P. Familletti, J. Ryan, J. Kao, 1992, The Journal of biological chemistry.

Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.

D. Connolly, A. Schmidt, D. Stern, 1993, Blood.

Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.

W. Hurley, A. Schmidt, C. Esposito, 1992, The Journal of biological chemistry.

Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II.

S. Libutti, S. Greenberg, J. Chabot, 1994, The Journal of biological chemistry.

A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response.

W. Kisiel, S. Greenberg, M. Clauss, 1994, The Journal of biological chemistry.

Interleukin-10 ablation promotes tumor development, growth, and metastasis.

Grace Y Chen, G. Núñez, W. Zou, 2012, Cancer research.

1 Interleukin ( IL )-10 ablation promotes tumor development , growth and metastasis

Grace Y Chen, G. Núñez, W. Zou, 2011 .

A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor.

S. Libutti, J. Chabot, D. Stern, 1996, The Journal of surgical research.

Endothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response.

D. Stern, M. Clauss, J. Kao, 1993, Behring Institute Mitteilungen.

Dual biological effects of the cytokines interleukin-10 and interferon-γ

W. Zou, J. Kao, Ilona Kryczek, 2011, Cancer Immunology, Immunotherapy.

Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease

W. Zou, J. Kao, Ilona Kryczek, 2011, Journal of Translational Medicine.

Mass Defect-Based N,N-Dimethyl Leucine Labels for Quantitative Proteomics and Amine Metabolomics of Pancreatic Cancer Cells.

Lingjun Li, C. Lietz, J. Kao, 2017, Analytical chemistry.